Projects per year
Personal profile
Research Strategic Pillar
The Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):
Research Strategic Pillar Keywords
- Infectious/ Immunological Health
Fingerprint
Dive into the research topics where William Lawrence is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Development of a Small Molecule Drug Anti-Toxin Therapeutic to Treat Anthrax in Humans
Lawrence, W. (PI)
Hawaii Biotech, Inc ( Award #HHSN272201800023C)
4/15/23 → 4/30/25
Project: Research project
-
Inactivation of aerosolized SARS-CoV-2 by Pisharodi devices
Lawrence, W. (PI)
South Texas Neurosurgery Associates ( Award # )
3/1/22 → 9/1/22
Project: Research project
-
Teixobactin Development for Anthrax
Lawrence, W. (PI)
NovoBiotic Pharmaceuticals, LLC ( Award #5R44AI15265702)
7/28/21 → 6/30/22
Project: Research project
-
Air Purification of Airborne SARS-CoV-2 by Genesis Air Technology
Lawrence, W. (PI)
4/1/21 → 11/1/22
Project: Research project
-
Aerus ActivePure Air Purifier Against Respiratory Pathogens
Lawrence, W. (PI)
Aerus Medical, LLC ( Award # )
3/1/21 → 12/31/24
Project: Research project
Research output
- 22 Article
-
A bacteriophage cocktail targeting Yersinia pestis provides strong post-exposure protection in a rat pneumonic plague model
Kilgore, P., Sha, J., Hendrix, E. K., Neil, B. H., Lawrence, W., Peel, J. E., Hittle, L., Woolston, J., Sulakvelidze, A., Schwartz, J. A. & Chopra, A. K., Nov 2024, In: Microbiology Spectrum. 12, 11, e00942-24.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Rapid in vitro activity of telavancin against Bacillus anthracis and in vivo protection against inhalation anthrax infection in the rabbit model
Lawrence, W. S., Peel, J. E., Slayden, R. A., Peterson, J., Baze, W. B., Hensel, M. E., Whorton, E. B., Beasley, D. W. C., Cummings, J. E. & Macias-Perez, I., Jul 9 2024, In: Antimicrobial agents and chemotherapy. 68, 7, p. e0011224Research output: Contribution to journal › Article › peer-review
Open Access -
Long-term Prophylaxis Against Aerosolized Marburg Virus in Nonhuman Primates With an Afucosylated Monoclonal Antibody
Abelson, D., Barajas, J., Stuart, L., Kim, D., Marimuthu, A., Hu, C., Yamamoto, B., Ailor, E., Whaley, K. J., Vu, H., Agans, K. N., Borisevich, V., Deer, D. J., Dobias, N. S., Woolsey, C., Prasad, A. N., Peel, J. E., Lawrence, W. S., Cross, R. W. & Geisbert, T. W. & 2 others, , Nov 15 2023, In: Journal of Infectious Diseases. 228, p. S701-S711Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Pathogenesis of Aerosolized Ebola Virus Variant Makona in Nonhuman Primates
Prasad, A. N., Fenton, K. A., Agans, K. N., Borisevich, V., Woolsey, C., Comer, J. E., Dobias, N. S., Peel, J. E., Deer, D. J., Geisbert, J. B., Lawrence, W. S., Cross, R. W. & Geisbert, T. W., Nov 15 2023, In: Journal of Infectious Diseases. 228, p. S604-S616Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
In Vivo Activity of Repurposed Amodiaquine as a Host-Targeting Therapy for the Treatment of Anthrax
Martchenko Shilman, M., Bartolo, G., Alameh, S., Peterson, J., Lawrence, W. S., Peel, J. E., Sivasubramani, S. K., Beasley, D. W. C., Cote, C. K., Demons, S. T., Halasahoris, S. A., Miller, L. L., Klimko, C. P., Shoe, J. L., Fetterer, D. P., McComb, R., Ho, C. L. C., Bradley, K. A., Hartmann, S. & Cheng, L. W. & 8 others, , Aug 13 2021, In: ACS Infectious Diseases. 7, 8, p. 2176-2191 16 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations